Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- revvity.com
- Sector
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Sede Central
- Waltham, United States
- Consejero Delegado
- Prahlad R. Singh
- Empleados
- 11 000
- Acciones en Circulación
- 111.59 M a 2026-08-06
- Capital Flotante
- 102.49 M
- Capitalización Bursátil
- 16.63 mil M USD
- Insiders
- 0.26%
- Inversores Institucionales
- 96.55%
- Industria (SIC)
- Laboratory Analytical Instruments
- Forma Jurídica
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Ratio de Reparto
- 13.4%
- FCF
- 558 M USD6%
- Deuda
- 3.21 mil M USD3.9 a. de FCF
- Racha de Dividendos
- 43 a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 05.07.2026 (el último informe de la compañía).
Descripción
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividendos
Revvity Inc. (RVTY) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 0.28 USD por acción (pagos: 4). Eso representa aproximadamente el 0.18% del precio actual de la acción. La próxima fecha ex-dividendo es el 23.10.2026: 0.07 USD por acción, con pago el 13.11.2026. Historial de dividendos ininterrumpido: 43 años.
| Fecha Ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 anunciado | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/0.2 % | trimestral | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.0/≈0.2 % | trimestral | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.0/≈0.2 % | trimestral | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | trimestral | US:RVTY |
Noticias de Esta Semana
Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.
| 06.10.2026 | Revvity to Host Investor Day |
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 M | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 M | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 M | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 M | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 M | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 M | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 M | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 M | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 M | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 M | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 M | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 M | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 M | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 M | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 M | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 M | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
